159 related articles for article (PubMed ID: 33707054)
1. The gliadin p31-43 peptide: Inducer of multiple proinflammatory effects.
Chirdo FG; Auricchio S; Troncone R; Barone MV
Int Rev Cell Mol Biol; 2021; 358():165-205. PubMed ID: 33707054
[TBL] [Abstract][Full Text] [Related]
2. p31-43 Gliadin Peptide Forms Oligomers and Induces NLRP3 Inflammasome/Caspase 1- Dependent Mucosal Damage in Small Intestine.
Gómez Castro MF; Miculán E; Herrera MG; Ruera C; Perez F; Prieto ED; Barrera E; Pantano S; Carasi P; Chirdo FG
Front Immunol; 2019; 10():31. PubMed ID: 30761127
[TBL] [Abstract][Full Text] [Related]
3. P31-43, an undigested gliadin peptide, mimics and enhances the innate immune response to viruses and interferes with endocytic trafficking: a role in celiac disease.
Nanayakkara M; Lania G; Maglio M; Auricchio R; De Musis C; Discepolo V; Miele E; Jabri B; Troncone R; Auricchio S; Barone MV
Sci Rep; 2018 Jul; 8(1):10821. PubMed ID: 30018339
[TBL] [Abstract][Full Text] [Related]
4. An undigested gliadin peptide activates innate immunity and proliferative signaling in enterocytes: the role in celiac disease.
Nanayakkara M; Lania G; Maglio M; Discepolo V; Sarno M; Gaito A; Troncone R; Auricchio S; Auricchio R; Barone MV
Am J Clin Nutr; 2013 Oct; 98(4):1123-35. PubMed ID: 23966426
[TBL] [Abstract][Full Text] [Related]
5. Gliadin peptide P31-43 localises to endocytic vesicles and interferes with their maturation.
Barone MV; Nanayakkara M; Paolella G; Maglio M; Vitale V; Troiano R; Ribecco MT; Lania G; Zanzi D; Santagata S; Auricchio R; Troncone R; Auricchio S
PLoS One; 2010 Aug; 5(8):e12246. PubMed ID: 20805894
[TBL] [Abstract][Full Text] [Related]
6. Structural insights on P31-43, a gliadin peptide able to promote an innate but not an adaptive response in celiac disease.
Calvanese L; Nanayakkara M; Aitoro R; Sanseverino M; Tornesello AL; Falcigno L; D'Auria G; Barone MV
J Pept Sci; 2019 May; 25(5):e3161. PubMed ID: 30912242
[TBL] [Abstract][Full Text] [Related]
7. Structural conformation and self-assembly process of p31-43 gliadin peptide in aqueous solution. Implications for celiac disease.
Herrera MG; Gómez Castro MF; Prieto E; Barrera E; Dodero VI; Pantano S; Chirdo F
FEBS J; 2020 May; 287(10):2134-2149. PubMed ID: 31659864
[TBL] [Abstract][Full Text] [Related]
8. Gliadin peptides as triggers of the proliferative and stress/innate immune response of the celiac small intestinal mucosa.
Barone MV; Troncone R; Auricchio S
Int J Mol Sci; 2014 Nov; 15(11):20518-37. PubMed ID: 25387079
[TBL] [Abstract][Full Text] [Related]
9. Lysosomal accumulation of gliadin p31-43 peptide induces oxidative stress and tissue transglutaminase-mediated PPARgamma downregulation in intestinal epithelial cells and coeliac mucosa.
Luciani A; Villella VR; Vasaturo A; Giardino I; Pettoello-Mantovani M; Guido S; Cexus ON; Peake N; Londei M; Quaratino S; Maiuri L
Gut; 2010 Mar; 59(3):311-9. PubMed ID: 19951908
[TBL] [Abstract][Full Text] [Related]
10. Mechanisms of innate immune activation by gluten peptide p31-43 in mice.
Araya RE; Gomez Castro MF; Carasi P; McCarville JL; Jury J; Mowat AM; Verdu EF; Chirdo FG
Am J Physiol Gastrointest Liver Physiol; 2016 Jul; 311(1):G40-9. PubMed ID: 27151946
[TBL] [Abstract][Full Text] [Related]
11. Gliadin-mediated proliferation and innate immune activation in celiac disease are due to alterations in vesicular trafficking.
Barone MV; Zanzi D; Maglio M; Nanayakkara M; Santagata S; Lania G; Miele E; Ribecco MT; Maurano F; Auricchio R; Gianfrani C; Ferrini S; Troncone R; Auricchio S
PLoS One; 2011 Feb; 6(2):e17039. PubMed ID: 21364874
[TBL] [Abstract][Full Text] [Related]
12. A celiac cellular phenotype, with altered LPP sub-cellular distribution, is inducible in controls by the toxic gliadin peptide P31-43.
Nanayakkara M; Kosova R; Lania G; Sarno M; Gaito A; Galatola M; Greco L; Cuomo M; Troncone R; Auricchio S; Auricchio R; Barone MV
PLoS One; 2013; 8(11):e79763. PubMed ID: 24278174
[TBL] [Abstract][Full Text] [Related]
13. Celiac anti-type 2 transglutaminase antibodies induce differential effects in fibroblasts from celiac disease patients and from healthy subjects.
Paolella G; Lepretti M; Barone MV; Nanayakkara M; Di Zenzo M; Sblattero D; Auricchio S; Esposito C; Caputo I
Amino Acids; 2017 Mar; 49(3):541-550. PubMed ID: 27613408
[TBL] [Abstract][Full Text] [Related]
14. Genistein antagonizes gliadin-induced CFTR malfunction in models of celiac disease.
Esposito S; Villella VR; Ferrari E; Monzani R; Tosco A; Rossin F; D'Eletto M; Castaldo A; Luciani A; Silano M; Bona G; Marseglia GL; Romani L; Piacentini M; Raia V; Kroemer G; Maiuri L
Aging (Albany NY); 2019 Apr; 11(7):2003-2019. PubMed ID: 30981209
[TBL] [Abstract][Full Text] [Related]
15. A pathogenic role for cystic fibrosis transmembrane conductance regulator in celiac disease.
Villella VR; Venerando A; Cozza G; Esposito S; Ferrari E; Monzani R; Spinella MC; Oikonomou V; Renga G; Tosco A; Rossin F; Guido S; Silano M; Garaci E; Chao YK; Grimm C; Luciani A; Romani L; Piacentini M; Raia V; Kroemer G; Maiuri L
EMBO J; 2019 Jan; 38(2):. PubMed ID: 30498130
[TBL] [Abstract][Full Text] [Related]
16. Structural analysis and Caco-2 cell permeability of the celiac-toxic A-gliadin peptide 31-55.
Iacomino G; Fierro O; D'Auria S; Picariello G; Ferranti P; Liguori C; Addeo F; Mamone G
J Agric Food Chem; 2013 Feb; 61(5):1088-96. PubMed ID: 23298305
[TBL] [Abstract][Full Text] [Related]
17. Enterocyte proliferation and signaling are constitutively altered in celiac disease.
Nanayakkara M; Lania G; Maglio M; Kosova R; Sarno M; Gaito A; Discepolo V; Troncone R; Auricchio S; Auricchio R; Barone MV
PLoS One; 2013; 8(10):e76006. PubMed ID: 24204586
[TBL] [Abstract][Full Text] [Related]
18. Biochemical modifications of gliadins induced by microbial transglutaminase on wheat flour.
Mazzeo MF; Bonavita R; Maurano F; Bergamo P; Siciliano RA; Rossi M
Biochim Biophys Acta; 2013 Nov; 1830(11):5166-74. PubMed ID: 23891939
[TBL] [Abstract][Full Text] [Related]
19. Association between innate response to gliadin and activation of pathogenic T cells in coeliac disease.
Maiuri L; Ciacci C; Ricciardelli I; Vacca L; Raia V; Auricchio S; Picard J; Osman M; Quaratino S; Londei M
Lancet; 2003 Jul; 362(9377):30-7. PubMed ID: 12853196
[TBL] [Abstract][Full Text] [Related]
20. The gliadin-CFTR connection: new perspectives for the treatment of celiac disease.
Maiuri L; Villella VR; Raia V; Kroemer G
Ital J Pediatr; 2019 Mar; 45(1):40. PubMed ID: 30898172
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
